Alliancebernstein L.P. Kaleido Biosciences, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $685 - $23,290	-13,700 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.3 - $2.7 $1,170 - $2,430	-900 Reduced 6.16%	13,700 $23,000
Q2 2021 Jul 30, 2021	BUY	$5.82 - $8.72 $9,312 - $13,952	1,600 Added 12.31%	14,600 $109,000
Q1 2021 May 06, 2021	SELL	$7.2 - $16.82 $5,040 - $11,774	-700 Reduced 5.11%	13,000 $105,000
Q3 2020 Nov 12, 2020	SELL	$5.09 - $11.07 $8,653 - $18,819	-1,700 Reduced 11.04%	13,700 $152,000
Q2 2020 Aug 13, 2020	BUY	$4.62 - $8.01 $71,148 - $123,354	15,400 New	15,400 $114,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.